Hi-Risk/Recurrent/Advanced PCa Video Chat, April 14, 2025

AnCan is grateful to the following sponsors for making this recording possible: Bayer, Foundation Medicine, Janssen, Myriad Genetics, Novartis, Telix, Blue Earth Diagnostic and Foundation Medicine.
If you missed any recent recordings, you’ll find a full list either on our YouTube Playlist or visit our Blog Post https://ancan.org/our-recent-blog-posts-in-case-you-missed-them/   Sign up for our Blog by checking the New Blog box at https://ancan.org/contact-us/
AnCan respectfully notes that it does not accept sponsored promotion. Any drugs, protocols or devices recommended in our discussions are based solely on anecdotal peer experience or clinical evidence.
AnCan cannot and does not provide medical advice. We encourage you to discuss anything you hear in our sessions with your own medical team.
AnCan reminds all Participants that Adverse Events experienced from prescribed drugs or protocols should be reported to the pharmaceutical manufacturer or the FDA Adverse Event Reporting System (FAERS). To do so call 1-800-332-1066 or download interactive FDA Form 3500 https://www.fda.gov/media/76299/download
All AnCan’s groups are free and drop-in … join us in person sometime!
Join our other free and drop in groups:

Editor’s Pick: Testosterone and estrogen return after stopping HT – and play tricks on two gents (rd)

Topics Discussed

Testosterone storms back – but so does estrogen!; Yale Smilow doc requests Dceipher test and MSKCC doc refuses; time for salvage protocol but Canadian protocols for RT and HT not exactly clear; bone biopsy may be best but least invasive method to determine if lesion is metastatic; hot flashes start with Intermittent Hormone Therapy – screwed up ‘sex’ hormones return; how many ways can we lower the HT dose?… or should we prior to at least 18 months duration.

Chat Log